A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents

Ascitic fluid and serum from rats with acute pancreatitis injure rat pancreatic tissues and alter the expression of heat shock protein 60

(2010) Yong-Yu Li et al.   CELL STRESS & CHAPERONES

Cannabinoids and the gut: New developments and emerging concepts

(2010) Angelo A. Izzo et al.   PHARMACOLOGY & THERAPEUTICS

Estradiol upregulates the expression of oxytocin receptor in colon in rats

(2009) Mei Feng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents

(2009) Simona Pisanti et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Melatonin and Trolox ameliorate duodenal LPS-induced disturbances and oxidative stress

(2009) D.S. Fagundes et al.   DIGESTIVE AND LIVER DISEASE

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Voltage-dependent Ca2+Current Identified in Freshly Isolated Interstitial Cells of Cajal (ICC) of Guinea-pig Stomach

(2009) Young Chul Kim et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus

(2009) y.-y. li et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

(2009) Vincenzo Di Marzo   PHARMACOLOGICAL RESEARCH

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

(2009) L. S. Whyte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

(2009) Angelo A. Izzo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice

(2008) R Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

(2008) A A Izzo et al.   GUT

2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55

(2008) S. Oka et al.   JOURNAL OF BIOCHEMISTRY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase

(2008) d. de filippis et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

GPR55: a new member of the cannabinoid receptor clan?

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

(2007) D G Johns et al.   BRITISH JOURNAL OF PHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY